Women with IVF will soon be able to incubate embryos within their bodies before being placed within their wombs.
A recent clinical trial means that the incubation device can function just as effectively as the IVF, but it costs a lot lesser than its alternative.
INVOcell is the shape of a cylinder which is placed within the vagina using a diaphragm that is flexible.
The embryos remain stored in the body at body temperature with gases like oxygen and carbon dioxide at the same levels that usually take place during the process of natural fertilization.
As soon as the embryos grow in balls of nearly one hundred cells, doctors remove the device and pick the most fitting embryo for the implant.
The clinical trial in the United States involved 40 women, 65 percent of whom became pregnant regardless of whether the conventional method was employed or not.
A total of 55 percent of the women using in-body incubation managed to give birth, contrary to 60 percent of the women who preferred the conventional means.
Kevin Doody from the Center for Assisted Reproduction is thoroughly pleased with the outcome of this clinical trial conducted in Bedford, Texas.
Incubators used in the process of conventional IVF need to be monitored on a regular basis to make sure that embryos have sufficient amount of gas for the five days that follow.
The human body itself functions as an incubator, so it eliminates the need for any costly equipment.
Doody believes that using less complicated devices in third world countries would make the most sense.
Any cases that involve more complications such as those where the sperm needs to be injected into an egg would be dealt in conventional clinics by most skilled doctors.
Doody is confident that the device would reduce the cost per cycle, significantly.